MedPath

Investigation of respiratory-related tumour motion in liver cancer patients undergoing stereotactic body radiotherapy (SBRT) using audiovisual (AV) biofeedback

Conditions
iver cancer
Motion management
Liver cancer
Cancer - Liver
Registration Number
ACTRN12613000110785
Lead Sponsor
niversity of Sydney
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot yet recruiting
Sex
All
Target Recruitment
30
Inclusion Criteria

1) Liver cancer patients, either primary hepatocellular carcinoma or liver metastases, eligible for stereotactic radiotherapy
2)> 18 years old
3)No gender or ethnic restrictions
4)Radio-opaque markers implanted (fiducials and/or surgical clips previously implanted in the liver)
5)Ability to give written informed consent and willingness to participate and comply with the study

Exclusion Criteria

1)Pregnant/ lactating women
2)<18 years old.
3)Prior radiotherapy treatment to the liver
4)Life expectancy less than 6 months
5)Non-liver cancer patients

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath